Adam Singer is a hematology/oncology fellow, health technology researcher, and Biodesign Translational fellow at UCLA. He is passionate about emerging health technologies and specializes in collaborations with health technology companies to run clinical studies of their products and services in patients in the academic setting. His active collaborations include the medical wearables company Vivalink and the clinical trials informational company Power. He has also advised several health technology companies, including Y Combinator alumnus DailyDoctor and Cedars-Sinai Accelerator alumnus Regard. He completed his internal medicine residency and received an MD from UCLA, a PhD in policy analysis from the Pardee RAND Graduate School, and a BA in molecular and cell biology from UC Berkeley.